| |
| |
|
| Insider
Information: |
Himawan Jeff |
| Relationship: |
Director, 10% Owner |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
12,883,056 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$15,934,855 |
|
|
| Total
Shares |
12,883,056 |
|
|
| Total
Value |
$15,934,855 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medicinova Inc |
MNOV |
Director |
|
0 |
2006-01-09 |
11,703,704 |
Premium* |
|
|
Horizon Pharma, Inc. |
HZNP |
Director |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
|
Gyre Therapeutics |
GYRE |
Director, 10% Owner |
2015-08-20 |
0 |
2015-08-20 |
1,179,352 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2023-10-06 |
4 |
D |
$116.50 |
$5,189,609 |
D/D |
(44,546) |
0 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2023-10-06 |
4 |
D |
$116.50 |
$5,182,153 |
I/I |
(44,482) |
0 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2023-09-26 |
4 |
OE |
$13.87 |
$446,073 |
D/D |
32,161 |
44,546 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2023-05-09 |
4 |
GA |
$0.00 |
$0 |
I/I |
7,873 |
7,873 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2023-05-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,873 |
2,121 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2023-04-28 |
4 |
D |
$111.16 |
$208,870 |
D/D |
(1,879) |
9,994 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2023-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,913 |
11,873 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2022-12-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,230 |
7,960 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2022-04-29 |
4 |
D |
$98.56 |
$112,260 |
I/I |
(1,139) |
57,063 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2022-04-29 |
4 |
OE |
$0.00 |
$0 |
I/I |
4,223 |
58,202 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2021-04-30 |
4 |
OE |
$0.00 |
$0 |
I/I |
11,098 |
53,979 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2020-05-02 |
4 |
D |
$35.62 |
$147,859 |
I/I |
(4,151) |
42,881 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2020-05-02 |
4 |
OE |
$0.00 |
$0 |
I/I |
15,390 |
47,032 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2019-05-03 |
4 |
D |
$26.54 |
$109,663 |
I/I |
(4,132) |
31,642 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2019-05-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
15,320 |
35,774 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2018-05-03 |
4 |
D |
$13.87 |
$52,567 |
I/I |
(3,790) |
20,454 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2018-05-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
14,054 |
24,244 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2017-05-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
13,953 |
13,953 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2017-05-03 |
4 |
D |
$15.12 |
$56,897 |
I/I |
(3,763) |
10,190 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • • |
2015-08-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,179,352 |
1,179,352 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2015-03-13 |
4 |
S |
$22.35 |
$7,985,364 |
I/I |
(357,287) |
0 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2015-03-12 |
4 |
S |
$22.59 |
$4,456,487 |
I/I |
(197,277) |
357,287 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2015-03-12 |
4 |
D |
$4.04 |
$548,381 |
I/I |
(135,805) |
554,564 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2015-03-12 |
4 |
OE |
$4.31 |
$2,974,110 |
I/I |
690,369 |
690,369 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2015-03-10 |
4 |
S |
$21.84 |
$28,062,544 |
I/I |
(1,284,915) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
